NIH-funded research R01 grant

Tailored follow-up care for thyroid cancer survivors

Official title: Risk-stratified care for thyroid cancer survivors

Funded at University of Michigan at Ann Arbor · NIH-11300961 · Data updated 2026-11-12

This project will create personalized follow-up plans to reduce unneeded tests and worry for people who have finished treatment for thyroid cancer.

More Cancer Survivors research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Michigan at Ann Arbor
NIH-funded
Lab location1 site (Ann Arbor, United States)
Project startApril 16, 2024
Project endMarch 31, 2029
Funding year2026
Award (this year)$656,594
NIH project number5R01CA281976-03
Project IDNIH-11300961 on NIH RePORTER

Who could benefit from this research

Could help

People who have completed initial treatment for thyroid cancer and want follow-up care that matches their personal recurrence risk are ideal candidates.

Less likely to help

Patients with aggressive, advanced, or ongoing active thyroid cancer that already requires close monitoring may not avoid intensive surveillance.

What this research studies

As a thyroid cancer survivor, I would have my long-term follow-up plan informed by real-world data from people like me in Georgia and Los Angeles County. The team will combine pathology reports, death records, patient reports, and doctor chart reviews to find who is at low versus higher risk of recurrence. They will check their findings using University of Michigan health data and then design follow-up care pathways that trade off benefits and harms. The goal is to make follow-up less burdensome for low-risk survivors while keeping careful watch for those more likely to need additional care.

Why it matters

Potential benefit: If successful, this could spare many survivors years of unnecessary tests, reduce anxiety, and focus monitoring on people who really need it.

How similar studies have gone: Some cancers have benefitted from risk-based surveillance, but applying and validating this personalized approach specifically for thyroid cancer is relatively new and needs more evidence.

Where this research is happening

  • University of Michigan at Ann Arbor
    Ann Arbor, United States
    Active

Researchers

  • Principal investigator: Haymart, Megan Rist — University of Michigan at Ann Arbor
  • Study coordinator: Haymart, Megan Rist

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.